Catherine Hanna

1.3k total citations
37 papers, 412 citations indexed

About

Catherine Hanna is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Catherine Hanna has authored 37 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 10 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Catherine Hanna's work include Colorectal Cancer Surgical Treatments (12 papers), Colorectal Cancer Screening and Detection (9 papers) and Colorectal and Anal Carcinomas (7 papers). Catherine Hanna is often cited by papers focused on Colorectal Cancer Surgical Treatments (12 papers), Colorectal Cancer Screening and Detection (9 papers) and Colorectal and Anal Carcinomas (7 papers). Catherine Hanna collaborates with scholars based in United Kingdom, Italy and Australia. Catherine Hanna's co-authors include Robert J. Jones, Bradford W. Hesse, Holly A. Massett, Anthony J. Chalmers, Sarah Jefferies, Helen Bulbeck, Kathleen Boyd, Ewelina Rogozińska, Robin Grant and Ashleigh Kernohan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Catherine Hanna

32 papers receiving 406 citations

Peers

Countries citing papers authored by Catherine Hanna

Since Specialization

Citations

This map shows the geographic impact of Catherine Hanna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Hanna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Hanna more than expected).

Fields of papers citing papers by Catherine Hanna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Hanna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Hanna. The network helps show where Catherine Hanna may publish in the future.

Co-authorship network of co-authors of Catherine Hanna

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Hanna. A scholar is included among the top collaborators of Catherine Hanna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Hanna. Catherine Hanna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neoadjuvant Treatment of Rectal Cancer: A Repeat UK-wide Survey After Implementation of National Intensity Modulated Radiotherapy Guidance 2025 ·Clinical Oncology ·Archie Macnair, Richard Adams, Ane Appelt, (unknown), K. Drinkwater, Catherine Hanna, Séan M. O’Cathail, R. Muirhead	0
2	Māori healthcare professionals’ perceptions of psychedelic-assisted therapy: a qualitative study 2025 ·New Zealand Medical Journal ·Catherine Hanna, (unknown), (unknown), Lisa Reynolds	0
3	Variation in colorectal cancer treatment and outcomes in Scotland: real world evidence from national linked administrative health data 2024 ·International Journal for Population Data Science ·(unknown), Catherine Hanna, (unknown), Hugh Paterson, Sarah H. Wild, Holly Ennis, Peter Hall	0
4	Cancer Trial Impact: Understanding Implementation of the Short Course Oncology Treatment (SCOT) Trial Findings in colorectal cancer at a National Level 2022 ·Clinical Oncology ·Catherine Hanna, (unknown), Peter Hall, Holly Ennis, Eva Morris, Philip McLoone, Kathleen Boyd, Robert J. Jones	2
5	Health economic studies of colorectal cancer and the contribution of administrative data: A systematic review 2021 ·European Journal of Cancer Care ·(unknown), Catherine Hanna, Peter Hall, Eva Morris	4
6	The Long and the Short of it: the Role of Short-course Radiotherapy in the Neoadjuvant Management of Rectal Cancer 2021 ·Clinical Oncology ·Finbar Slevin, Catherine Hanna, Ane Appelt, Chris Cunningham, Corrie A.M. Marijnen, David Sebag‐Montefiore, R. Muirhead	6
7	Immune Checkpoint Inhibition as a Strategy in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer 2021 ·SHILAP Revista de lepidopterología ·Catherine Hanna, Séan M. O’Cathail, Janet Graham, Richard Adams, Campbell S.D. Roxburgh	2
8	Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020 2021 ·Clinical Oncology ·Catherine Hanna, Finbar Slevin, Ane Appelt, (unknown), Richard Adams, (unknown), Matthew Beasley, Aileen Duffton, Alexandra Gilbert, Simon Gollins, (unknown), M. Hawkins, Kristine Laws, Séan M. O’Cathail, Pierluigi Porcu, (unknown), David Sebag‐Montefiore, (unknown), (unknown), R. Muirhead	19
9	Do clinical trials change practice? A longitudinal, international assessment of colorectal cancer prescribing practices 2021 ·Cancer Treatment and Research Communications ·Catherine Hanna, Kathleen Boyd, (unknown), Janet Graham, Timothy Iveson, Robert J. Jones, Richard H. Wilson	5
10	Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact Analysis 2021 ·Clinical Colorectal Cancer ·Catherine Hanna, (unknown), Andrew Briggs, Andrea Harkin, Caroline Kelly, John McQueen, Karen Allan, Sarah Pearson, Niels Henrik Holländer, Bengt Glimelius, Ramón Salazar, Eva Segelov, Mark Saunders, Timothy Iveson, Robert J. Jones, Kathleen Boyd	2
11	Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT) 2021 ·Radiation Oncology ·Catherine Hanna, Séan M. O’Cathail, Janet Graham, Mark Saunders, Leslie Samuel, Mark Harrison, (unknown), Joanne Edwards, Daniel R. Gaya, Caroline Kelly, Liz-Anne Lewsley, Noori Maka, (unknown), (unknown), Susan Dillon, (unknown), Jonathan Platt, Fiona Thomson, Richard Adams, Campbell S.D. Roxburgh	13
12	Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis 2020 ·Cochrane Database of Systematic Reviews ·Catherine Hanna, Theresa A Lawrie, Ewelina Rogozińska, Ashleigh Kernohan, Sarah Jefferies, Helen Bulbeck, (unknown), Tomos Robinson, Robin Grant	49
13	P-335 Self-reported prescribing practices in the setting of adjuvant treatment for colorectal cancer 2020 ·Annals of Oncology ·Catherine Hanna, Kathleen Boyd, Robert J. Jones	3
14	Evidencing the impact of cancer trials: insights from the 2014 UK Research Excellence Framework 2020 ·Trials ·Catherine Hanna, (unknown), Kathleen Boyd, Kathryn A. Robb, Robert J. Jones	10
15	Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial 2020 ·Neuro-Oncology ·Catherine Hanna, Kathreena M. Kurian, Karin Williams, Colin Watts, Alan Jackson, Ross Carruthers, Karen Strathdee, Garth Cruickshank, Laurence Dunn, Sara Erridge, Lisa Godfrey, Sarah Jefferies, Catherine McBain, (unknown), Alex McCormick, Marc Pittman, Sarah Halford, Anthony J. Chalmers	98
16	Radiotherapy Trial Set-up in the UK: Identifying Inefficiencies and Potential Solutions 2019 ·Clinical Oncology ·Catherine Hanna, (unknown), Jonathan Wadsley, (unknown), Shamaila Anwar, Elizabeth Miles, (unknown), Emma Hall, Charlotte E. Coles, Gerard G. Hanna	6
17	Challenges to Treating Older Glioblastoma Patients: the Influence of Clinical and Tumour Characteristics on Survival Outcomes 2017 ·Clinical Oncology ·(unknown), Catherine Hanna, Frank Saran, Anthony J. Chalmers, (unknown)	27
18	Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer 2016 ·PLoS ONE ·Vincenza Conteduca, Simon J. Crabb, Robert J. Jones, Orazio Caffo, Tony Elliott, Emanuela Scarpi, Paolo Fabbri, Lisa Derosa, Francesco Massari, Gianmauro Numico, (unknown), Catherine Hanna, Francesca Maines, H Joyce, Cristian Lolli, Ugo De Giorgi	42
19	Association Between Early PSA Increase and Clinical Outcome in Patients Treated with Enzalutamide for Metastatic Castration Resistant Prostate Cancer 2016 ·Molecular Diagnosis & Therapy ·Vincenza Conteduca, Simon J. Crabb, Emanuela Scarpi, Catherine Hanna, Francesca Maines, H Joyce, Paolo Fabbri, Lisa Derosa, Francesco Massari, Cristian Lolli, (unknown), Robert J. Jones, Orazio Caffo, Tony Elliott, Ugo De Giorgi	8
20	Outside the Box: Will Information Technology Be a Viable Intervention to Improve the Quality of Cancer Care? 2010 ·JNCI Monographs ·Bradford W. Hesse, Catherine Hanna, Holly A. Massett, (unknown)	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact